A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B
Clinical trial NCT02065011 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02065011
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-12
- Primary completion
- 2031-06-13
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.